Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPAR.L Regulatory News (PAR)

  • There is currently no data for PAR

Issue of Equity

17 Sep 2010 09:14

RNS Number : 8720S
Noventa Limited
17 September 2010
 

Noventa Limited

 

("Noventa" or the "Company")

 

Placing of New Shares & the Issue of Shares and Options to Employees & Directors

 

17 September 2010

 

Further to the announcement of the placing and subscription of new shares made on 3 September 2010, ("Original Placing") Noventa (AIM: NVTA) is pleased to announce the successful delayed placing of a further 9,773,080 new ordinary shares of 0.04p each ("Placing Shares") at a price of 6.5p per Placing Share, raising a total of £635,250 (approximately equivalent to US$991,000). These funds will be utilised for a combination of capital expenditure and general working capital purposes. The Placing Shares have been acquired by a combination of new investors and existing shareholders. Religare Capital Markets acted as the Company's broker in the placing. 

 

The issue of the Placing Shares combined with the monies raised announced on 3 September 2010 means that Noventa has secured in total £5,882,250 (approximately equivalent to US$9,071,380).

 

In conjunction with the Original Placing, the subscribers will receive warrants to subscribe for ordinary shares on the same terms as investors who participated in the Original Placing. As such, the subscribers for the Placing Shares will receive warrants to subscribe for 1 new ordinary 0.04p shares for every 2 shares subscribed for (the "Warrants"). The Warrants will have an exercise price of 10p and an expiry date of 7 September 2012. 7 September 2012 is also the revised expiry date of the warrants announced on 3 September 2010 in order to maintain consistency. The Warrants will not be traded on any exchange.

 

Further to the announcement made on 3 September 2010 regarding the potential new tantalum deposit at the Marropino site, the Company will now await full analysis of this new find before deciding whether or not it requires further capital. The Company does not envisage raising any further capital, whether debt or equity until this analysis is complete.

 

An application has been made to admit the Placing Shares to trading on AIM and trading is expected to commence on 22 September 2010.

 

The Company also announces the issue of 693,614 new ordinary shares of 0.04p ("Bonus Shares") as bonuses to employees and consultants of the Company, in recognition of the hard work and achievement in bringing the mine back into production. In addition, the Company announces the granting of options over 485,612 new ordinary shares of 0.04p at an exercise price of 6.5p per share to Mr. Kean Chung, a director of the Company, in order to bring his remuneration in line with the other Non-Executive Directors. Mr. Chung's options have a term of 7 years. An application has been made to admit the Bonus Shares to trading on AIM and trading is expected to commence on 23 September 2010.

 

Following the issue of the Placing Shares and the Bonus Shares the Company will have 319,196,497 ordinary shares of 0.04p each in issue and following the issue of all 29,859,511 of the Additional Subscription Shares (as defined in the Company's 'Issue of Equity' announcement of 3 September 2010) the Company will have 349,056,008 ordinary shares of 0.04p each in issue. The Company does not hold any shares in treasury.

Barons Financial Services (UK) Limited, ("BFSUK") a company authorised and regulated by the Financial Services Authority acted as a placing agent on behalf of Religare Capital Markets during this fundraising, for which it will receive a net commission share of £36,521. BFSUK, in which Mr. Kohn has a beneficial interest through its Swiss parent company, is a Related Party as defined under the AIM Rules for Companies. The independent Directors (all Directors other than Mr. Kohn), who have consulted with the Company's nominated adviser, believe the terms of the placing commission to BFSUK, to be fair and reasonable in so far as shareholders are concerned.

 

Following the issue of the Placing Shares, the list of disclosed shareholders in Noventa, as far as the Company is aware, will be as follows:

 

Shares Held

Percentage

Highland African Ventures Limited #

79,373,079

24.87%

Fidelity Investments Limited

24,170,000

7.57%

JMM Trading LP

15,103,557

4.73%

BlackRock Investment Management

14,732,208

4.62%

Marlborough UK Micro-Cap Growth Fund

11,983,988

3.75%

 

 # Highland African Ventures Limited is owned by a trust whose trustee is Fleming Family & Partners Liechtenstein and Mr. R J Fleming is one of the potential beneficiaries. Fleming Family & Partners Liechtenstein has a total interest, including through Highland African Ventures Limited, in a total of 89,203,154 shares (28.01% of the issued shares). Mr. R J Fleming has an interest, including through Highland African Ventures Limited, in a total of 85,208,892 shares (26.75% of the issued shares).

 

Chairman Eric Kohn TD commented: "We are delighted that the shareholders of Noventa, both old and new, continue to support and share our vision for the Company." 

 

 

 

For further information please contact:

 

Eric F. Kohn TD

Chairman

Noventa Limited

+41 22 8500560

+41 79 5030150

www.noventa.net

 

Nick Harriss/Emily Staples

Religare Capital Markets (Nomad)

+44 20 7444 0800

 

Daniel Briggs Religare Capital Markets (Broker) +44 20 7444 0500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELRMPTMBBBMJM
Date   Source Headline
22nd Sep 20147:00 amRNSStrategy Change and Issue of Convertible Loan Note
9th Jun 20148:30 amRNSIssue of convertible loan notes
3rd Jun 20147:00 amRNSChange of Registered Office
26th Mar 20147:30 amRNSSuspension - Paragon Resources plc
26th Mar 20147:00 amRNSStatement re. Suspension
25th Mar 20147:01 amRNSHolding in Company
19th Mar 20147:00 amRNSIssue of Equity
3rd Mar 201410:15 amRNSIssue of Equity
24th Feb 20147:00 amRNSAcquisition of interest in Paragon Volta Limited
6th Feb 201410:45 amRNSDirector Shareholding
3rd Feb 201410:46 amRNSHalf Yearly Report
10th Jan 20143:00 pmRNSHolding in Company
27th Nov 201312:25 pmRNSResult of AGM
21st Nov 20137:00 amRNSIssue of Equity
4th Nov 20133:30 pmRNSNotice of AGM
30th Oct 201311:00 amRNSInvestment in Greenstar, Appointment of CEO etc...
3rd Sep 201310:00 amRNSIssue of Equity
22nd Aug 20132:16 pmRNSAppointment of special adviser to the Board
12th Aug 20137:00 amRNSCancellation of contract & appointment of Director
8th Aug 20137:00 amRNSIssue of Equity
30th Jul 201310:28 amRNSFinal Results and appointment of Director
24th Jul 20134:26 pmRNSResult of Class Meeting
17th Jul 201312:45 pmRNSAdjournment of class meeting
11th Jul 20134:35 pmRNSPrice Monitoring Extension
24th Jun 201311:30 amRNSUpdate on Sales Process
21st Jun 20133:00 pmRNSIssue of Equity & Change of Name
19th Jun 20132:12 pmRNSResult of EGM
12th Jun 20132:16 pmRNSAdjournment of Class Meeting and EGM
3rd Jun 201311:00 amRNSUpdate Sale Process
15th May 201311:08 amRNSNotice of EGM
11th Apr 201310:00 amRNSDirectorate Change and Settlement Agreement
18th Mar 201311:16 amRNSIssue of Equity and Trading Update
1st Mar 20137:00 amRNSUpdate on Operations
11th Feb 20137:41 amRNSProduction update
5th Feb 201312:15 pmRNSCease to be reporting issuer in Canada
17th Jan 20137:00 amRNSPreference Share Dividend
28th Dec 20123:21 pmRNSShipment of Tantalum Pentoxide Concentrate
14th Dec 20121:00 pmRNSCease to be a reporting issuer in Canada
29th Nov 201212:00 pmRNSHolding(s) in Company
28th Nov 20127:00 amRNSOperations Update
23rd Nov 20127:00 amRNSCompletion of Secured Loan Financing Agreement
20th Nov 20128:39 amRNSLoan Extension
9th Nov 20123:59 pmRNSLoan Extension
1st Nov 201211:11 amRNSLoan Extension
11th Oct 20127:00 amRNSPreference Share Dividend
28th Sep 201212:45 pmRNSLoan Extension
28th Sep 20127:00 amRNSHalf Yearly Report
11th Sep 20127:00 amRNSDirectorate Change
31st Aug 20129:37 amRNSLoan Extension
17th Aug 20124:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.